Financials Qingdao NovelBeam Technology Co.,Ltd.

Equities

688677

CNE100005410

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 03:30:00 25/06/2024 am IST 5-day change 1st Jan Change
39.62 CNY -1.32% Intraday chart for Qingdao NovelBeam Technology Co.,Ltd. -5.08% -25.57%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 8,185 9,829 6,475 4,772 - -
Enterprise Value (EV) 1 8,185 9,829 6,475 4,772 4,772 4,772
P/E ratio 66.7 x 53.8 x 44.4 x 22 x 16.9 x 14.3 x
Yield 0.44% 0.71% 1.03% 1.51% 2.02% 2.6%
Capitalization / Revenue 26.4 x 20.6 x 13.8 x 7.89 x 6.2 x 5.1 x
EV / Revenue 26.4 x 20.6 x 13.8 x 7.89 x 6.2 x 5.1 x
EV / EBITDA 57.3 x 45.7 x 35.2 x 19.4 x 13.8 x 12.3 x
EV / FCF - 3,57,54,78,427 x - - - -
FCF Yield - 0% - - - -
Price to Book 7.5 x 8.06 x 5.01 x 3.29 x 2.81 x 2.38 x
Nbr of stocks (in thousands) 1,21,772 1,21,772 1,21,637 1,20,434 - -
Reference price 2 67.21 80.71 53.23 39.62 39.62 39.62
Announcement Date 25/04/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 309.7 476.8 470.6 605.1 770 935.8
EBITDA 1 - 142.8 214.9 183.8 245.9 345.8 387
EBIT 1 - 133.9 206.3 161 229.2 308.6 377.6
Operating Margin - 43.25% 43.27% 34.2% 37.88% 40.08% 40.35%
Earnings before Tax (EBT) 1 - 133.2 205.5 160.2 228.8 307.8 376.9
Net income 1 96.35 117.7 182.6 145.7 219.2 284.9 338.1
Net margin - 38.02% 38.29% 30.96% 36.24% 37% 36.13%
EPS 2 1.057 1.007 1.500 1.200 1.803 2.343 2.780
Free Cash Flow - - 2.749 - - - -
FCF margin - - 0.58% - - - -
FCF Conversion (EBITDA) - - 1.28% - - - -
FCF Conversion (Net income) - - 1.51% - - - -
Dividend per Share 2 - 0.2929 0.5714 0.5500 0.6000 0.8000 1.030
Announcement Date 26/03/21 25/04/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 117.6
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 38.44
Net margin 32.68%
EPS -
Dividend per Share -
Announcement Date 24/04/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - 2.75 - - - -
ROE (net income / shareholders' equity) - 12.7% 15.9% 11.6% 14% 16.1% 16.7%
ROA (Net income/ Total Assets) - 9.96% 14.2% 10.5% 12.6% 14.9% 15.7%
Assets 1 - 1,182 1,288 1,392 1,747 1,908 2,161
Book Value Per Share 2 - 8.960 10.00 10.60 12.10 14.10 16.70
Cash Flow per Share 2 - 0.8500 0.8600 1.300 1.730 1.890 2.560
Capex 1 - 100 102 55.9 43.2 56.2 41.6
Capex / Sales - 32.32% 21.31% 11.87% 7.15% 7.3% 4.44%
Announcement Date 26/03/21 25/04/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
39.62 CNY
Average target price
60.75 CNY
Spread / Average Target
+53.33%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688677 Stock
  4. Financials Qingdao NovelBeam Technology Co.,Ltd.